High Grade B-Cell Lymphoma — Trials

High Grade B-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

142 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 84
Recruiting: 45
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 46.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04205838	Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma	terminated	Phase 2	23	Jonsson Comprehensive Cancer CenterOTHER	1	Feb 27, 2026	clinicaltrials
NCT04358458	First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas	terminated	Phase 1 / Phase 2	46	GenmabINDUSTRY	5	Oct 24, 2024	clinicaltrials